Digital Diabetes Management Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Digital Diabetes Management Market covers analysis by Product & Service (Devices, and Software & Services), Type (Wearable Devices and Handheld Devices), End User (Home Care, Hospitals & Specialty Diabetes Clinics, and Academic & Research Institutes), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00003092
  • Category : Medical Device
  • No. of Pages : 150

Digital Diabetes Management Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

Diabetes is a medical condition where blood glucose, or blood sugar, levels are too high. It is a metabolic disorder associated with the hormone insulin and can lead to severe condition with many complications if left untreated. Hence, management of diabetes is essential as maintaining the blood sugar levels in diabetes is challenging. Thus, diabetes management includes keeping the count on carbohydrate intake, measuring and recording the blood sugar level, track record of exercise and other activities.

The digital diabetes management market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of type I and type II diabetes, growing obesity, and technological advancements in digital diabetes management devices. Moreover, regulatory approvals for new and advanced digital diabetes management pose growing opportunities for the growth of the global digital diabetes management market.

The "Global Digital Diabetes Management Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global digital diabetes management market with detailed market segmentation by product and services, type, end user and geography. The global digital diabetes management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading digital diabetes management market players and offers key trends and opportunities in the market.

The global digital diabetes management market is segmented on the basis of product and services, type, end user. Based on product and services, the digital diabetes management market is segmented as devices and software and services. The devices market is further segmented into smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps/closed loop systems & smart insulin patches. By type the market is segmented into wearable devices, handheld devices. Based on end user, the digital diabetes management market is segmented as home care, hospitals & specialty diabetes clinics, and academic & research institutes.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Digital Diabetes Management market based on product and services, type, and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The digital diabetes management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the digital diabetes management market in the forecast period, due to the increasing prevalence of diabetes, advanced healthcare infrastructure, availability of technologically advanced products in this region as well as the presence of major market players in this region. However, Asia Pacific region is expected to be the fastest growing region owing to availability of several untapped opportunities, and increasing adoption rate of insulin devices in Asian countries, such as India and China.

The report analyzes factors affecting digital diabetes management market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Digital Diabetes Management market in these regions.

The report also includes the profiles of key digital diabetes management companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the Digital Diabetes Management market include Medtronic, F. Hoffmann-La Roche Ltd, Glooko, Inc., Omada Health, Inc, B. Braun Melsungen AG, Abbott, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care Holdings AG, and Smart Meter LLC. among others.

REGIONAL FRAMEWORK

Digital Diabetes Management Market Report Analysis

Digital Diabetes Management Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Medtronic
  • F Hoffmann La Roche Ltd
  • Glooko Inc
  • Omada Health Inc
  • B Braun Melsungen AG
  • Abbott
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care Holdings AG

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Product & Service
  • Devices
  • Software & Services
Market Segment By Type
  • Wearable Devices and Handheld Devices
Market Segment By End User
  • Home Care
  • Hospitals & Specialty Diabetes Clinics
  • Academic & Research Institutes
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

Digital Diabetes Management Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product & Service
  • Devices
  • Software & Services
By Type
  • Wearable Devices and Handheld Devices
By End User
  • Home Care
  • Hospitals & Specialty Diabetes Clinics
  • Academic & Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • F Hoffmann La Roche Ltd
  • Glooko Inc
  • Omada Health Inc
  • B Braun Melsungen AG
  • Abbott
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care Holdings AG
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

The List of Companies

1. Medtronic
2. F. Hoffmann-La Roche Ltd
3. Glooko, Inc.
4. Omada Health, Inc.
5. B. Braun Melsungen AG
6. Abbott
7. Insulet Corporation
8. Tandem Diabetes Care
9. Ascensia Diabetes Care Holdings AG
10. Smart Meter LLC.

Trends and growth analysis reports related to Medical Device : READ MORE..